In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series C round brings $30mm to Pathwork Diagnostics

Executive Summary

New buyer Alta Partners led a $30mm Series C round for Pathwork Diagnostics Inc. (molecular tests for cancer), and takes a seat on the company's board. Existing investors Abingworth, Advent Venture Partners, Novus Ventures, Prospect Venture Partners, and Venrock also participated. Pathwork will use the proceeds to launch its Pathwork tissue-of-origin diagnostic, the first of its kind to gain FDA approval.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register